Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Total Current Liabilities: 2018-2021

Historic Total Current Liabilities for Black Diamond Therapeutics (BDTX) over the last 2 years, with Sep 2021 value amounting to $26.4 million.

  • Black Diamond Therapeutics' Total Current Liabilities rose 132.44% to $26.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $26.4 million, marking a year-over-year increase of 132.44%. This contributed to the annual value of $14.2 million for FY2020, which is 192.37% up from last year.
  • Latest data reveals that Black Diamond Therapeutics reported Total Current Liabilities of $26.4 million as of Q3 2021, which was up 12.24% from $23.5 million recorded in Q2 2021.
  • In the past 5 years, Black Diamond Therapeutics' Total Current Liabilities registered a high of $26.4 million during Q3 2021, and its lowest value of $2.6 million during Q4 2018.
  • Moreover, its 3-year median value for Total Current Liabilities was $12.8 million (2020), whereas its average is $14.1 million.
  • Data for Black Diamond Therapeutics' Total Current Liabilities shows a peak YoY surged of 282.57% (in 2021) over the last 5 years.
  • Over the past 4 years, Black Diamond Therapeutics' Total Current Liabilities (Quarterly) stood at $2.6 million in 2018, then surged by 88.85% to $4.9 million in 2019, then surged by 192.37% to $14.2 million in 2020, then skyrocketed by 132.44% to $26.4 million in 2021.
  • Its Total Current Liabilities was $26.4 million in Q3 2021, compared to $23.5 million in Q2 2021 and $18.7 million in Q1 2021.